Aurinia Pharmaceuticals (AUPH) stock Forecast for 2021 – 2025

Aurinia Pharmaceuticals (AUPH) stock Forecast for 2022 – 2026

Last update: 05-19-2022, 16:46

Sector: Healthcare

The share price of Aurinia Pharmaceuticals Inc. (AUPH) now

What analysts predict:: $22.83

52-week high/low: $33.97 / $8.86

50/200 Day Moving Average: $11.35 / $17.92

This figure corresponds to the average price over the previous 50/200 days. For Aurinia Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Aurinia Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Aurinia Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aurinia Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Aurinia Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Aurinia Pharmaceuticals stock? When should I record a loss on Aurinia Pharmaceuticals stock? What are analysts' forecasts for Aurinia Pharmaceuticals stock? What is the future of Aurinia Pharmaceuticals stock?

We forecast Aurinia Pharmaceuticals stock performance using neural networks based on historical data on Aurinia Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aurinia Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aurinia Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Aurinia Pharmaceuticals stock

The chart below shows the historical price of Aurinia Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aurinia Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Aurinia Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 21 11.87 11.51 12.11 5.20
May 22 11.88 11.34 12.33 8.80
May 23 12.05 11.78 12.37 4.97
May 24 12.34 12.00 12.56 4.69
May 25 12.36 12.11 12.58 3.92
May 26 12.44 12.01 13.01 8.33
May 27 12.56 12.15 12.74 4.84
May 28 12.54 12.20 12.78 4.75
May 29 12.18 12.02 12.62 4.99
May 30 11.83 11.60 12.18 5.02
May 31 11.74 11.54 12.14 5.19
Jun 01 12.43 12.27 12.74 3.83
Jun 02 12.98 12.61 13.46 6.73
Jun 03 13.22 12.64 13.38 5.90
Jun 04 13.72 13.54 13.97 3.16
Jun 05 14.37 13.75 14.55 5.83
Jun 06 15.06 14.87 15.33 3.10
Jun 07 15.50 14.85 15.74 6.01
Jun 08 14.62 14.05 15.06 7.24
Jun 09 13.78 13.32 14.34 7.64
Jun 10 13.76 13.15 14.00 6.47
Jun 11 13.16 12.56 13.68 8.93
Jun 12 13.05 12.43 13.51 8.76
Jun 13 12.99 12.37 13.50 9.14
Jun 14 13.54 13.37 13.77 2.98
Jun 15 13.54 13.19 13.82 4.74
Jun 16 13.31 13.00 13.91 7.00
Jun 17 13.32 12.87 13.49 4.84
Jun 18 12.77 12.60 12.99 3.10
Jun 19 12.28 11.88 12.61 6.08

Aurinia Pharmaceuticals Daily Price Targets


Aurinia Pharmaceuticals Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $11.87. Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 4.939%.

Pessimistic target level: 11.51

Optimistic target level: 12.11


Aurinia Pharmaceuticals Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $11.88. Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 8.090%.

Pessimistic target level: 11.34

Optimistic target level: 12.33


Aurinia Pharmaceuticals Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $12.05. Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 4.735%.

Pessimistic target level: 11.78

Optimistic target level: 12.37


Aurinia Pharmaceuticals Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $12.34. Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 4.479%.

Pessimistic target level: 12.00

Optimistic target level: 12.56


Aurinia Pharmaceuticals Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $12.36. Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 3.772%.

Pessimistic target level: 12.11

Optimistic target level: 12.58


Aurinia Pharmaceuticals Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $12.44. Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 7.690%.

Pessimistic target level: 12.01

Optimistic target level: 13.01


AUPH (AUPH) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 10.63 10.02 11.43 12.35
Jul. 11.33 10.48 12.58 16.71
Aug. 11.24 9.89 11.87 16.67
Sep. 10.92 9.82 11.34 13.40
Oct. 11.04 10.12 12.36 18.14
Nov. 11.94 10.41 13.37 22.14
Dec. 12.36 11.37 13.94 18.44

Aurinia Pharmaceuticals forecast for this year


Aurinia Pharmaceuticals Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $10.6338. Pessimistic: $10.02. Optimistic: $11.43


Aurinia Pharmaceuticals Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $11.3314. Pessimistic: $10.48. Optimistic: $12.58


Aurinia Pharmaceuticals Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $11.2408. Pessimistic: $9.89. Optimistic: $11.87


Aurinia Pharmaceuticals Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $10.917. Pessimistic: $9.82. Optimistic: $11.34


Aurinia Pharmaceuticals Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $11.0393. Pessimistic: $10.12. Optimistic: $12.36


Aurinia Pharmaceuticals Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $11.9401. Pessimistic: $10.41. Optimistic: $13.37


Aurinia Pharmaceuticals Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $12.3604. Pessimistic: $11.37. Optimistic: $13.94




Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 12.87 12.05 14.52 17.02
Feb 13.80 13.29 14.95 11.08
Mar 11.88 10.89 13.12 16.96
Apr 12.74 12.27 13.80 11.08
May 13.69 12.86 14.13 8.99
Jun 14.04 12.94 15.32 15.54
Jul 15.39 13.91 17.14 18.82
Aug 14.16 12.91 15.11 14.54
Sep 16.22 14.43 17.44 17.26
Oct 15.86 14.64 16.49 11.23
Nov 14.59 13.82 15.71 12.04
Dec 16.29 14.21 18.33 22.47

Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 16.74 16.01 17.70 9.53
Feb 16.60 15.17 17.24 12.02
Mar 17.48 16.25 18.38 11.57
Apr 15.10 14.02 16.31 14.07
May 14.89 13.84 16.01 13.54
Jun 15.98 14.52 17.87 18.74
Jul 14.91 13.40 15.79 15.11
Aug 16.55 14.54 17.85 18.55
Sep 17.88 16.62 20.02 17.00
Oct 19.28 17.52 20.17 13.15
Nov 18.97 17.42 20.37 14.46
Dec 16.33 15.28 16.93 9.72



Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 15.52 14.97 17.18 12.86
Feb 14.75 13.07 15.34 14.77
Mar 15.55 14.21 16.35 13.09
Apr 17.52 16.51 18.14 8.96
May 16.73 15.13 18.15 16.67
Jun 19.09 17.23 21.41 19.54
Jul 19.49 18.74 21.45 12.65
Aug 21.51 19.69 24.13 18.40
Sep 20.96 19.02 22.54 15.63
Oct 18.72 17.34 21.05 17.64
Nov 19.25 18.24 20.06 9.06
Dec 18.79 16.42 20.03 18.02

Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 18.46 16.93 19.08 11.30
Feb 17.69 16.79 19.00 11.62
Mar 20.33 19.68 22.60 12.95
Apr 20.55 18.78 21.41 12.29
May 22.89 20.58 23.80 13.54
Jun 21.61 19.36 23.96 19.19
Jul 22.23 19.78 24.97 20.80
Aug 24.97 23.33 26.09 10.57
Sep 25.57 22.54 27.86 19.09
Oct 26.75 23.46 29.41 20.23
Nov 24.23 23.41 27.17 13.84
Dec 24.07 21.53 26.89 19.91

Aurinia Pharmaceuticals information and performance

Aurinia Pharmaceuticals Inc. is a late stage clinical biopharmaceutical company. The company focuses on the development and commercialization of treatments for target groups of patients with serious illnesses. Voklosporin develops for several indications. Voclosporine is an exploratory therapy. He is developing voklosporin for the treatment of lupus nephritis (LN) and other proteinuric diseases. He also puts forward the solution of Voclosporin Ophthalmic (VOC), a topical formation, for the treatment of dry eye syndrome (DES). Voclosporin is a calcineurin inhibitor (CNI). By inhibiting calcineurin, voclosporin blocks IL-2 expression and T-cell mediated immune responses and stabilizes the podocyte in the kidney.

Aurinia Pharmaceuticals Address

#1203-4464 MARKHAM STREET, VICTORIA BC, BC, CA

Market Capitalization: 1 574 754 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -58 641 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.399

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.532

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 1428.57

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 14.95

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 141742000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.